Comparative study on inhibitory activity of zerumbone and zerumbone 2,3-epoxide on NF-κB activation and NO production

Scientia Pharmaceutica

Volumn 77, Issue 3, 2009, Pages 589-595

  Giang, Phan M ^a   Son, Phan T ^a   Jin, Hui Z ^b   Lee, Jeong H ^b   Lee, Jung J ^b  

^a VIETNAM NATIONAL UNIVERSITY   (Viet Nam)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

NF B; NO production; Zerumbone; Zerumbone 2,3 epoxide

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SESQUITERPENOID; UNCLASSIFIED DRUG; ZERUMBONE; ZERUMBONE 2,3 EPOXIDE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG STRUCTURE; IC 50; MOUSE; NONHUMAN;

EID: 70349278677     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.0907-16     Document Type: Article

References (13)

1. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J Clin Invest. 2001; 107: 135-142. doi:10.1172/JCI11914 (Pubitemid 32096826)
2. Zingerelli B, Sheehan M, Wong HR. Nuclear factor-κB as a therapeutic target in critical care medicine. Crit Care Med. 2003; 31 (Suppl. 1): 105-111. doi:10.1097/00003246-200301001-00015 (Pubitemid 36143484)
3. Makarov SS. NF-κB as a therapeutic target in chronic inflammation: recent advances. Mol Med Today. 2000; 6: 441-447. doi:10.1016/S1357-4310(00) 01814-1
4. Epinat JC, Gilmore TD. Diverse agents act at multiple levels to inhibit the Rel/NF-κB signal transduction pathway. Oncogene. 1999; 18: 6896-6909. doi:10.1038/sj.onc.1203218
5. Murakami A, Takahashi D, Kinoshita T, Koshimizu K, Kim HW, Yoshihiro A, Nakamura Y, Jiwajinda S, Terao J, Ohigashi H. Zerumbone, a Southeast Asian ginger sesquiterpene, markedly supresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: the α,β- unsaturated carbonyl group is a prerequisite. Carcinogenesis. 2002; 23: 795-802. doi:10.1093/carcin/23.5.795 (Pubitemid 34567518)
6. Takada Y, Murakami A, Aggarwal BB. Zerumbone abolishes NF-κB and IκB kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene. 2005; 24: 6957-6969. doi:10.1038/sj.onc.1208845 (Pubitemid 41509418)
7. Murakami A, Shigemori T, Ohigashi H. Zingiberaceous and Citrus Constituents, 1′-Acetoxychavicol acetate, zerumbone, auraptene, and nobiletin, suppress lipopolysaccharide-induced Cyclooxygenase-2 expression in RAW264.7 murine macrophages through different modes of action. J Nutr. 2005; 135 (Suppl 12): 2987S-2992S. PMid:16317159 (Pubitemid 43156577)
8. Lee JH, KooTH, Hwang BY, Lee JJ. Kaurane diterpene, kamenbakaurin, inhibits NF-κB by directly targeting the DNA-binding activity of p50 and blocks the expresion of antiapoptotic NF-κB target genes. J Biol Chem. 2002; 277: 18411-18420. doi:10.1074/jbc.M201368200
9. Rüngeler P, Castro V, Mora G, Gören N, Vichnewski W, Pahl HL, Merfort I, Schmidt TJ. Inhibition of transcription factor NF-κB by sesquiterpene lactones: a proposed molecular mechanism of action. Bioorg Med Chem. 1999; 7: 2343-2352. doi:10.1016/S0968-0896(99)00195-9 (Pubitemid 30122736)
10. Phan MG, Van NH, Phan TS. [Sesquiterpenoids from the rhizomes of Curcuma zedoaria (Berg.) Roscoe of Vietnam]. Tap Chi Hoa Hoc [J Chem (Vietnam)]. 1998; 36: 70-73.
11. Vo VC. Dictionary of Vietnamese Medicinal Plants. Ho Chi Minh city: Medicine, 1997: p. 741.
12. Kitayama T, Yamamoto K, Utsumi R, Takatani M, Hili RK, Kawai Y, Sawada S, Okamoto T. Chemistry of zerumbone. 2. Regulation of ring bond cleavage and unique antibacterial activities of zerumbone derivatives. Biosci Biotechnol Biochem. 2001; 65: 2193-2199. doi:10.1271/bbb.65.2193
13. Matthes HWD, Luu B, Ourisson G. Cytotoxic components of Zingiber zerumbet, Curcuma zedoaria and C. domestica. Phytochemistry. 1980; 19: 2643-2650. doi:10.1016/S0031-9422(00)83937-0